Relmada Therapeutics, Inc. (RLMD)
7.01
+0.26
(+3.85%)
USD |
NASDAQ |
Apr 08, 16:00
7.01
0.00 (0.00%)
After-Hours: 20:00
Relmada Therapeutics Total Assets (Quarterly) : 94.00M for Dec. 31, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Catalyst Pharmaceuticals, Inc. | 1.107B |
| Theravance Biopharma, Inc. | 485.57M |
| Avalo Therapeutics, Inc. | 117.70M |
| AN2 Therapeutics, Inc. | 61.95M |
| ACADIA Pharmaceuticals, Inc. | 1.564B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 7.492M |
| Shareholders Equity (Quarterly) | 86.51M |
| Current Ratio | 14.62 |